Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRC-4016 in mixed dyslipidemia
NCT01972178Phase 2Terminated
- Sponsor
- Pronova BioPharma
- Start
- Nov 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of icosabutate in mixed dyslipidemia, sponsored by Pronova BioPharma. Started Nov 2013; status: terminated.
02
Drugs
icosabutate
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT01972178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01972178.